FDA issued a Warning Letter to Hospira Healthcare India Pvt. Ltd. on 3/4/2019 for a later inspection.
483 Hospira Healthcare India Feb 2015

483 Hospira Healthcare India Feb 2015

Sandra Hughes FDA, Andrew Idzior FDA$119.00 - Available Now

FDA investigators audited the Hospira Healthcare India - Sriperumbudur, India facility and issued 8 inspectional observations (via FDA 483) on 04 Feb 2015.

Product details

  • Category: Human Drugs
  • Number of Observations: 8
  • Inspection end: 04 Feb 2015
  • Location: Sriperumbudur, India
  • FEI: 3008386908
Add To Cart